Go offline with the Player FM app!
BTOG 2024 Highlights
Manage episode 414815806 series 2424442
Tune in to an insightful podcast hosted by VJOncology, featuring experts from BTOG 2024 discussing advancements in lung cancer research.
Prof. Charles Swanton (Francis Crick Institute, London, UK) delves into the link between air pollution and cancer development. Dr Thomas Newsom-Davies (Chelsea and Westminster Hospital NHS Foundation Trust, London, UK) highlights progress in TNM staging and immunotherapy. Dr Mariana Brandao (Institute Jules Bordet, Brussels, Belgium) addresses operability in non-small cell lung cancer, stressing the need for thorough assessments. Dr Robert Rintau (University of Cambridge & Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK) discusses implications of improved survival rates and evolving treatments. Dr Crispin Hiley (UCL, London, UK) reflects on the HIT-Meso trial, while Prof. Sanjay Popat (The Royal Marsden NHS Foundation Trust, London, UK) underscores the success of BTOG 2024 in representing multidisciplinary teams. Explore the dynamic landscape of lung cancer treatment and research. Listen now for valuable insights.
The post BTOG 2024 Highlights appeared first on VJOncology.
174 episodes
Manage episode 414815806 series 2424442
Tune in to an insightful podcast hosted by VJOncology, featuring experts from BTOG 2024 discussing advancements in lung cancer research.
Prof. Charles Swanton (Francis Crick Institute, London, UK) delves into the link between air pollution and cancer development. Dr Thomas Newsom-Davies (Chelsea and Westminster Hospital NHS Foundation Trust, London, UK) highlights progress in TNM staging and immunotherapy. Dr Mariana Brandao (Institute Jules Bordet, Brussels, Belgium) addresses operability in non-small cell lung cancer, stressing the need for thorough assessments. Dr Robert Rintau (University of Cambridge & Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK) discusses implications of improved survival rates and evolving treatments. Dr Crispin Hiley (UCL, London, UK) reflects on the HIT-Meso trial, while Prof. Sanjay Popat (The Royal Marsden NHS Foundation Trust, London, UK) underscores the success of BTOG 2024 in representing multidisciplinary teams. Explore the dynamic landscape of lung cancer treatment and research. Listen now for valuable insights.
The post BTOG 2024 Highlights appeared first on VJOncology.
174 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.